Literature DB >> 7827927

Systemic responses in patients with intermittent claudication after treadmill exercise.

A T Edwards1, A D Blann, V J Suarez-Mendez, A M Lardi, C N McCollum.   

Abstract

The effect of 5 min treadmill exercise was investigated in claudicant patients and healthy controls; systemic neutrophil count, plasma thromboxane and von Willebrand's factor (a marker for endothelial injury) were measured. Median (interquartile range (i.q.r.)) resting neutrophil count was 5.6 (5.2-6.0) x 10(6) cells l-1 in claudicants and 2.8 (2.6-3.2) x 10(6) l-1 in controls (P < 0.05); this increased in those with claudication to 7.1 (6.2-7.7) x 10(6) l-1 immediately after exercise (P < 0.05). The resting plasma thromboxane level was 32.1 (25.0-60.0) pg ml-1 in claudicants and rose to 135.0 (104.0-141.3) pg ml-1 15 min after exercise, compared with a rise from 25.0 (22.0-33.5) to 55.5 (33.0-67.0) pg ml-1 in controls (P < 0.05). The resting serum von Willebrand's factor level was 127 (110-135) units dl-1 in claudicants compared with 60 (48-71) units dl-1 in controls; this difference persisted after exercise (P < 0.01). In patients with claudication, the level of von Willebrand's factor increased to 150 (140-156) units dl-1 60 min after exercise (P < 0.05). Free radical scavenging capacity was also investigated by measuring the plasma antioxidant activity of glutathione peroxidase and its essential non-metal cofactor selenium. Scavenging capacity was lower in claudicant patients whose median (i.q.r.) glutathione peroxidase activity (change in absorbance per min per ml plasma) was 2.84 (2.39-3.61) versus 3.24 (3.06-3.79) in controls (P < 0.05). Similarly, plasma concentrations of selenium were lower in claudicants at a median (i.q.r.) of 75.0 (58.0-81.0) micrograms l-1 compared with 88.0 (75.0-92.5) micrograms l-1 in controls (P < 0.05). Exercise in claudicant patients leads to neutrophilia and thromboxane production with subsequent endothelial injury. The antioxidant activity of glutathione peroxidase is reduced in patients with claudication and may allow the unopposed action of free radicals to damage endothelium.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7827927     DOI: 10.1002/bjs.1800811211

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  11 in total

Review 1.  The effect of exercise on coagulation and fibrinolysis factors in patients with peripheral arterial disease.

Authors:  Nikolaos Patelis; Georgios Karaolanis; Georgios N Kouvelos; Collin Hart; Sean Metheiken
Journal:  Exp Biol Med (Maywood)       Date:  2016-07-20

2.  Intermittent claudication should not be treated by surgery.

Authors:  M J Phillips; A R Cowan; C D Johnson
Journal:  Ann R Coll Surg Engl       Date:  1997-07       Impact factor: 1.891

3.  Peripheral artery disease affects the function of the legs of claudicating patients in a diffuse manner irrespective of the segment of the arterial tree primarily involved.

Authors:  Todd J Leutzinger; Panagiotis Koutakis; Matthew A Fuglestad; Hafizur Rahman; Holly Despiegelaere; Mahdi Hassan; Molly Schieber; Jason M Johanning; Nick Stergiou; G Matthew Longo; George P Casale; Sara A Myers; Iraklis I Pipinos
Journal:  PLoS One       Date:  2022-07-13       Impact factor: 3.752

4.  Association of monocyte tumor necrosis factor α expression and serum inflammatory biomarkers with walking impairment in peripheral artery disease.

Authors:  Reena L Pande; Jonathan Brown; Stewart Buck; Whitney Redline; Jeanne Doyle; Jorge Plutzky; Mark A Creager
Journal:  J Vasc Surg       Date:  2014-08-02       Impact factor: 4.268

Review 5.  Exercise training and peripheral arterial disease.

Authors:  Tara L Haas; Pamela G Lloyd; Hsiao-Tung Yang; Ronald L Terjung
Journal:  Compr Physiol       Date:  2012-10       Impact factor: 9.090

6.  Haemostasis, inflammation and renal function following exercise in patients with intermittent claudication on statin and aspirin therapy.

Authors:  Patrick Collins; Isobel Ford; Bernard Croal; Derek Ball; Michael Greaves; Ewan Macaulay; Julie Brittenden
Journal:  Thromb J       Date:  2006-07-18

7.  Von Willebrand factor propeptide as a marker of disease activity in systemic sclerosis (scleroderma).

Authors:  A Scheja; A Akesson; P Geborek; M Wildt; C B Wollheim; F A Wollheim; U M Vischer
Journal:  Arthritis Res       Date:  2001-02-19

Review 8.  Oxidative Stress in Peripheral Arterial Disease (PAD) Mechanism and Biomarkers.

Authors:  Salvatore Santo Signorelli; Salvatore Scuto; Elisa Marino; Anastasia Xourafa; Agostino Gaudio
Journal:  Antioxidants (Basel)       Date:  2019-09-02

Review 9.  Oxidative stress and antioxidant treatment in patients with peripheral artery disease.

Authors:  Panagiotis Koutakis; Ahmed Ismaeel; Patrick Farmer; Seth Purcell; Robert S Smith; Jack L Eidson; William T Bohannon
Journal:  Physiol Rep       Date:  2018-04

Review 10.  Lower extremity arterial disease in patients with diabetes: a contemporary narrative review.

Authors:  Mathilde Nativel; Louis Potier; Laure Alexandre; Laurence Baillet-Blanco; Eric Ducasse; Gilberto Velho; Michel Marre; Ronan Roussel; Vincent Rigalleau; Kamel Mohammedi
Journal:  Cardiovasc Diabetol       Date:  2018-10-23       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.